Cargando…

A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving

BACKGROUND: Patients with cirrhosis and ascites experience frequent hospital admissions, leading to poor quality of life and high healthcare costs. Monitoring weight is a component of ascites care and telemonitoring may improve outcomes and costs. Goals We aimed to evaluate the cost and outcomes of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bloom, Patricia P., Ventoso, Martin, Tapper, Elliot, Ha, Jasmine, Richter, James M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136259/ https://www.ncbi.nlm.nih.gov/pubmed/34018070 http://dx.doi.org/10.1007/s10620-021-07013-2

Ejemplares similares

A Smartphone App to Manage Cirrhotic Ascites Among Outpatients: Feasibility Study
por: Bloom, Patricia, et al.
Publicado: (2020)

Ayurvedic management of cirrhotic ascites
por: Aswathy, G., et al.
Publicado: (2016)

Management of refractory cirrhotic ascites: challenges and solutions
por: Fukui, Hiroshi, et al.
Publicado: (2018)

Current approaches to the management of patients with cirrhotic ascites
por: Garbuzenko, Dmitry Victorovich, et al.
Publicado: (2019)

Surgical Treatment of Cirrhotic Ascites
Publicado: (1927)

Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites
por: Huang, Lin-Lin, et al.
Publicado: (2014)

Management of Cirrhotic Ascites under the Add-on Administration of Tolvaptan
por: Adachi, Takuya, et al.
Publicado: (2021)

Comment on ‘Ascitic Fluid Analysis in the Differential Diagnosis of Ascites: Focus on Cirrhotic Ascites’
por: Ahmed, Furqan
Publicado: (2017)

A Metabolomic Analysis of Cirrhotic Ascites
por: Beyoğlu, Diren, et al.
Publicado: (2022)

The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX(©) Catheter
por: Reinglas, Jason, et al.
Publicado: (2016)

Optimal Management of Cirrhotic Ascites: A Review for Internal Medicine Physicians
por: Gallo, Andrea, et al.
Publicado: (2020)

High mortality of pneumonia in cirrhotic patients with ascites
por: Hung, Tsung-Hsing, et al.
Publicado: (2013)

Cost Saving or Cost Effective? Unanswered Questions in the Screening of Patients With Nonalcoholic Fatty Liver Disease
por: Jiang, Z. Gordon, et al.
Publicado: (2019)

The Evaluation of Serum Ascites Albumin Gradient and Portal Hypertensive changes in Cirrhotic Patients with Ascites
por: Shahed, Forhad Hossain Md, et al.
Publicado: (2016)

Cardiac dysfunction in cirrhotic portal hypertension with or without ascites
por: Dadhich, Sunil, et al.
Publicado: (2014)

Bacteriologic study of cirrhotic patients with non-neutrocytic ascites
por: Dabiri, Hossein, et al.
Publicado: (2014)

Alteration of the serum microbiome composition in cirrhotic patients with ascites
por: Santiago, Alba, et al.
Publicado: (2016)

Impact of continued administration of tolvaptan on cirrhotic patients with ascites
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Predictors of Spontaneous Bacterial Peritonitis in Patients with Cirrhotic Ascites
por: Metwally, Khaled, et al.
Publicado: (2018)

Undifferentiated shock in a cirrhotic patient: Ascites matters
por: Xenou, Antigoni, et al.
Publicado: (2021)

The incidence and natural history of ascites after liver transplantation
por: Bloom, Patricia P., et al.
Publicado: (2023)

The Role of Serum Procalcitonin Levels in Predicting Ascitic Fluid Infection in Hospitalized Cirrhotic and Non-cirrhotic Patients
por: Cekin, Yesim, et al.
Publicado: (2013)

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia
por: Wang, Shuzhen, et al.
Publicado: (2018)

Ascitic Bacterial Composition Is Associated With Clinical Outcomes in Cirrhotic Patients With Culture-Negative and Non-neutrocytic Ascites
por: Chen, Yanfei, et al.
Publicado: (2018)

Impact on 30-d readmissions for cirrhotic patients with ascites after an educational intervention: A pilot study
por: Lim, Nicholas, et al.
Publicado: (2019)

Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites
por: Kalambokis, Georgios N., et al.
Publicado: (2011)

Consensus care recommendations for alfapump(®) in cirrhotic patients with refractory or recurrent ascites
por: Aagaard, Niels Kristian, et al.
Publicado: (2022)

Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites
por: Hosui, Atsushi, et al.
Publicado: (2021)

Serum and ascitic D-dimer in cirrhotic patients with spontaneous bacterial peritonitis
por: El Gohary, Ahmed M., et al.
Publicado: (2021)

Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites
por: Hirooka, Masashi, et al.
Publicado: (2022)

Urea Transporter Inhibitor 25a Reduces Ascites in Cirrhotic Rats
por: Ying, Yi, et al.
Publicado: (2023)

Telemonitoring: use in the management of hypertension
por: Sivakumaran, Darshi, et al.
Publicado: (2014)

Telemonitoring in Heart Failure Management
por: Planinc, Ivo, et al.
Publicado: (2020)

Cost Comparison of Treatment Alternatives for Pleural Effusion and Ascites from a Payer Perspective: Are There Cost Savings from Indwelling Catheters?
por: Siefen, Ann-Cathrine, et al.
Publicado: (2023)

The First Year of Noninvasive Remote Telemonitoring in Chronic Heart Failure Is not Cost Saving but Improves Quality of Life: The Randomized Controlled CardioBBEAT Trial
por: Völler, Heinz, et al.
Publicado: (2022)

An unusual presentation of cirrhotic pleural effusion in a patient with no ascites: a case report
por: John, Savio, et al.
Publicado: (2009)

Splanchnic and Systemic Hemodynamics in Cirrhotic Patients With Refractory Ascites. Effect of Peritoneovenous Shunting
por: Vons, Corinne, et al.
Publicado: (1991)

Comparison of the effect of midodrine versus octreotide on hemodynamic status in cirrhotic patients with ascites
por: Minakari, Mohammad, et al.
Publicado: (2011)

Moderate hyperkalemia in hospitalized patients with cirrhotic ascites indicates a poor prognosis
por: Wallerstedt, Sven, et al.
Publicado: (2013)

Sarcopenia as a Useful Predictor for Long-Term Mortality in Cirrhotic Patients with Ascites
por: Kim, Tae Yeob, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_32kl05ifd458qie2gvngmled3p